Classification of intramural metastases and lymph node metastases of esophageal cancer from gene expression based on boosting and projective adaptive resonance theory

Journal of Bioscience and Bioengineering

Volumn 102, Issue 1, 2006, Pages 46-52

  Takahashi, Hiro ^a,b,c   Aoyagi, Kazuhiko ^c   Nakanishi, Yukihiro ^c   Sasaki, Hiroki ^c   Yoshida, Teruhiko ^c   Honda, Hiroyuki ^b  

^a Nagoya University ^*  (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

boosting; cancer classification; esophageal cancer; intramural metastases; projective adaptive resonance theory

Indexed keywords

BIOMARKERS; DIAGNOSIS; DNA; FUZZY SETS; GENES; PATIENT MONITORING;

BOOSTING; CANCER CLASSIFICATION; ESOPHAGEAL CANCER; INTRAMURAL METASTASES; PROJECTIVE ADAPTIVE RESONANCE THEORY;

TUMORS;

CYCLIN DEPENDENT KINASE 6; TUMOR MARKER;

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA MICROARRAY; ESOPHAGUS CANCER; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC SELECTION; HUMAN; HUMAN TISSUE; INTRAMURAL METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MARKER GENE; METASTASIS; NUCLEOTIDE SEQUENCE; PREDICTION; RELIABILITY; THEORETICAL MODEL;

ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TUMOR MARKERS, BIOLOGICAL;

EID: 33746357162     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.102.46     Document Type: Article

References (17)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94 (2001) 153-156
2. Igaki H., Kato H., Tachimori Y., Sato H., Daiko H., and Nakanishi Y. Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. Eur. J. Cardiothorac. Surg. 19 (2001) 887-893
3. Ando T., Suguro M., Hanai T., Kobayashi T., Honda H., and Seto M. Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma. Jpn. J. Cancer Res. 93 (2002) 1207-1212
4. Guyon I., Weston J., Barnhill S., and Vapnik V. Gene selection for cancer classification using support vector machines. Mach. Learn. 46 (2002) 389-422
5. Takahashi H., and Honda H. A new reliable cancer diagnosis method using boosted fuzzy classifier with a SWEEP operator method. J. Chem. Eng. Jpn. 38 (2005) 763-773
6. Takahashi H., and Honda H. Prediction of peptide binding to major histocompatibility complex class II molecules through use of boosted fuzzy classifier with SWEEP operator method. J. Biosci. Bioeng. 101 (2006) 137-141
7. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., Coller H., Loh M.L., Downing J.R., Caligiuri M.A., Bloomfield C.D., and Lander E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
8. Takahashi H., Kobayashi T., and Honda H. Construction of robust prognostic predictors by using projective adaptive resonance theory as a gene filtering method. Bioinformatics 21 (2005) 179-186
9. Noguchi H., Hanai T., Honda H., Harrison L.C., and Kobayashi T. Fuzzy neural network-based prediction of the motif for MHC class II binding peptides. J. Biosci. Bioeng. 92 (2001) 227-231
10. Schapire R.E. The strength of weak learnability. Mach. Learn. 5 (1990) 197-227
11. Freund Y., and Schapire R.E. A decision-theoretic generalization of online learning and an application to boosting. J. Comput. Syst. Sci. 55 (1997) 119-139
12. Friedman J., Hastie T., and Tibshirani R. Additive logistic regression: a statistical view of boosting. Ann. Stat. 28 (2000) 337-407
13. Freund Y. An adaptive version of the boost by majority algorithm. Mach. Learn. 43 (2000) 293-318
14. Horikawa S., Furuhashi T., and Uchikawa Y. On fuzzy modeling using fuzzy neural networks with the back-propagation algorithm. IEEE Trans. Neural Netw. 3 (1992) 801-806
15. Mendrzyk F., Radlwimmer B., Joos S., Kokocinski F., Benner A., Stange D.E., Neben K., Fiegler H., Carter N.P., Reifenberger G., Korshunov A., and Lichter P. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J. Clin. Oncol. 23 (2005) 8853-8862
16. Garcia J.F., Camacho F.I., Morente M., Fraga M., Montalban C., Alvaro T., Bellas C., Castano A., Diez A., Flores T., Martin C., Martinez M.A., Mazorra F., Menarguez J., Mestre M.J., Mollejo M., Saez A.I., Sanchez L., and Piris M.A. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 101 (2003) 681-689
17. Henshall S.M., Quinn D.I., Lee C.S., Head D.R., Golovsky D., Brenner P.C., Delprado W., Stricker P.D., Grygiel J.J., and Sutherland R.L. Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients. Clin. Cancer Res. 7 (2001) 544-550